Causes of death among people living with metastatic cancer

Kyle Mani,Daxuan Deng,Christine Lin,Ming Wang,Melinda L. Hsu,Nicholas G. Zaorsky

DOI: https://doi.org/10.1038/s41467-024-45307-x

IF: 16.6

2024-02-19

Nature Communications

Abstract:Abstract Studying survivorship and causes of death in patients with advanced or metastatic cancer remains an important task. We characterize the causes of death among patients with metastatic cancer, across 13 cancer types and 25 non-cancer causes and predict the risk of death after diagnosis from the diagnosed cancer versus other causes (e.g., stroke, heart disease, etc.). Among 1,030,937 US (1992–2019) metastatic cancer survivors, 82.6% of patients (n = 688,529) died due to the diagnosed cancer, while 17.4% (n = 145,006) died of competing causes. Patients with lung, pancreas, esophagus, and stomach tumors are the most likely to die of their metastatic cancer, while those with prostate and breast cancer have the lowest likelihood. The median survival time among patients living with metastases is 10 months; our Fine and Gray competing risk model predicts 1 year survival with area under the receiver operating characteristic curve of 0.754 (95% CI [0.754, 0.754]). Leading non-cancer deaths are heart disease (32.4%), chronic obstructive and pulmonary disease (7.9%), cerebrovascular disease (6.1%), and infection (4.1%).

multidisciplinary sciences

What problem does this paper attempt to address?

The problem this paper attempts to address is:

To study the survival rates and causes of death in patients with advanced or metastatic cancer, particularly to better understand the mortality associated with 13 different types of cancer and 25 non-cancer causes, and to predict the risk of death from primary metastatic cancer or other causes (such as stroke, heart disease, etc.) after diagnosis.

Specifically, the main objectives of the paper include:
1. **Describing causes of death**: To describe the causes of death in patients with metastatic cancer based on the site of disease, year of diagnosis, and survival time after diagnosis.
2. **Predicting risk of death**: To predict the risk of death from the diagnosed metastatic cancer or other causes within 1 year, 3 years, and 5 years after diagnosis.

Through these studies, the authors hope to identify patient groups at high risk of death and specific causes of death related to their diagnosed cancer, thereby providing valuable guidance to key stakeholders in the healthcare industry (including patients, providers, and payers). This helps in formulating comprehensive guidelines to improve the care of metastatic cancer survivors.